文献速递免疫规划卫生政策与健康促进

美国19-64岁肺炎球菌病风险升高成人中肺炎球菌疫苗接种知识、态度与实践调查

Pneumococcal vaccination knowledge, attitudes, and practices among surveyed U.S. adults aged 19-64 years at increased risk for pneumococcal disease.
PubMed 文献 · Vaccine · 2025-09-15

2024年1月对美国19-64岁风险合格成人开展网络调查,1533名合格参与者中39.2%自报已接种肺炎球菌疫苗;未接种者对疾病熟悉度和感知风险更低、更不愿在医务人员推荐后接种,常见未接种原因为不了解疫苗合格风险条件和缺乏医务人员推荐。

要点

  • 1533名19-64岁风险合格成人中39.2%自报已接种肺炎球菌疫苗。
  • 未接种者较接种者对肺炎球菌病更不熟悉、感知风险更低。
  • 未接种者更不愿在医务人员推荐后接种肺炎球菌疫苗。

核心结论

  • 需要采取多方面措施,包括优化医务人员和患者教育,以提高风险合格成人的疫苗接种覆盖率。

研究设计与样本

  • 2024年1月开展的网络调查,纳入1533名19-64岁风险合格成人,考察其对肺炎球菌疫苗接种的知识、态度与实践。

主要发现

  • 1533名合格参与者中39.2%自报已接种肺炎球菌疫苗。
  • 与已接种者相比,未接种者对肺炎球菌病更不熟悉且感知风险更低,在医务人员推荐后也更不愿接种肺炎球菌疫苗。
  • 常见未接种原因包括不了解疫苗合格风险条件和缺乏医务人员推荐。

关键数值与推荐

  • 2024年10月前,免疫实践咨询委员会推荐19-64岁风险合格成人接种肺炎球菌疫苗。
  • 截至2023年,疫苗接种覆盖率仍低(33.1%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pneumococcal disease contributes to significant morbidity in the United States. Before October 2024, the Advisory Committee on Immunization Practices recommended pneumococcal vaccination for risk-eligible adults aged 19-64 years; however, as of 2023, vaccination coverage remained low (33.1 %). To understand factors associated with low vaccination coverage, in January 2024, a web-based survey was conducted among risk-eligible adults aged 19-64 years examining their knowledge, attitudes, and practices toward pneumococcal vaccination. Of 1533 eligible participants, 39.2 % self-reported having received pneumococcal vaccination. Compared with vaccinated participants, unvaccinated participants were less familiar with and had lower perceived risk of pneumococcal disease and were less willing to receive pneumococcal vaccination following healthcare provider recommendation. Common reasons for not being vaccinated were lack of understanding of vaccine-qualifying risk conditions and lack of healthcare provider recommendations. A multi-faceted approach, including optimization of provider and patient education, is necessary to increase vaccination coverage among risk-eligible adults.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ramachandran V, Tangney S, Gedlinske A, et al. Pneumococcal vaccination knowledge, attitudes, and practices among surveyed U.S. adults aged 19-64 years at increased risk for pneumococcal disease. Vaccine. 2025. PMID: 40957308. doi:10.1016/j.vaccine.2025.127739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。